Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells

Details for Australian Patent Application No. 2006257940 (hide)

Owner University of Maryland - Baltimore Alba Therapeutics Corp.

Inventors Fasano, Alessio; Paterson, Blake; Sapone, Anna

Agent Davies Collison Cave

Pub. Number AU-A-2006257940

PCT Pub. Number WO2006/135811

Priority 60/688,693 09.06.05 US

Filing date 9 June 2006

Wipo publication date 21 December 2006

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2006/135811 Priority application(s): WO2006/135811

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006257945-Alkylquinoline and alkylquinazoline kinase modulators

2006257938-Thermoplastic polymer compositions including silica-containing nucleating agents